. . . . . . . . . . . . . "p(HGNC:MAPK1) -> p(HGNC:XIAP)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Treatment of melanoma cells with either TRAIL or U0126, a MEK inhibitor could not induce significant reduction in XIAP expression levels, but when the agents were combined there was marked decrease in the percentage of XIAP-positive cells, suggesting that TRAIL-induced XIAP was upregulated by ERK2." . . "Selventa" . . . . "2014-07-03T14:30:12.859+02:00"^^ . . .